Epsilon M&A Deal Report - Elitech Groupe

Transaction Multiples for the Valuation of Private Companies

Private Group Led by Ergon Capital Partners > Elitech Groupe

Announced Date : 10 November 2010

Type : LBO (Leverage Buy Out)

Deal Value : Yes

Acquirer : Private Group Led by Ergon Capital Partners

Target Elitech Groupe

Target Country France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> ELITech Group is an independent manufacturer and distributor of in vitro diagnostic equipment, tests and reagents focused on small to medium-sized, proximity and emergency diagnostic ...

No EMAT : 22168

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
29/09/2010	Private Group led by Pragma Capital	IMV Technologies	France	0
08/03/2009	Merck & Co	Intervet Schering-Plough Animal Health	Netherlands	0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database